Clinical Trial Update: Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial for relapsed or refractory B-cell acute lymphoblastic leukemia or lymphoblastic lymphoma sponsored by MedImmune; the study was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Snippet

Sponsor: MedImmune LLC | Conditions: B-Cell Pediatric ALL | Phase 2 | Status: TERMINATED | Results posted: 2017-02-27